True Wealth Design’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.6K | Sell |
14
-285
| -95% | -$93.6K | ﹤0.01% | 838 |
|
2025
Q1 | $80.8K | Buy |
299
+147
| +97% | +$39.7K | 0.03% | 120 |
|
2024
Q4 | $35.8K | Sell |
152
-2
| -1% | -$471 | 0.01% | 231 |
|
2024
Q3 | $42.4K | Buy |
154
+153
| +15,300% | +$42.1K | 0.02% | 166 |
|
2024
Q2 | $243 | Sell |
1
-1
| -50% | -$243 | ﹤0.01% | 734 |
|
2024
Q1 | $299 | Buy |
2
+1
| +100% | +$150 | ﹤0.01% | 713 |
|
2023
Q4 | $192 | Hold |
1
| – | – | ﹤0.01% | 682 |
|
2023
Q3 | $178 | Hold |
1
| – | – | ﹤0.01% | 662 |
|
2023
Q2 | $190 | Hold |
1
| – | – | ﹤0.01% | 657 |
|
2023
Q1 | $201 | Hold |
1
| – | – | ﹤0.01% | 730 |
|
2022
Q4 | $238 | Buy |
+1
| New | +$238 | ﹤0.01% | 637 |
|